A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader
Article Details
Authors (40)
Monica C. Rodrigo-Brenni
Jasper C. Komen
Ghaith M. Hamza
Natacha Bohin
Tomas Adomavicius
Angelo Andres
Stefan Blaho
Ulf Börjesson
Gavin W. Collie
Gian Marco De Donatis
Frederik Eisele
Ning Gao
Division of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences
Andrea Gohlke
Christoph Grebner
Frida Gustafsson
Andreas Hock
Cecilia Kankkonen
Praveen Kumar
Emilyanne Leonard
Xin Li
Ruth Macdonald
Katja Madeyski-Bengtson
Eric Miele
Philip Nevin
Jeroen Overman
Fiona Pachl
Claudio Pathe
Matthew W. D. Perry
Christopher Phillips
Andy Pike
Ian Purvis
Timothy Rasmusson
Sophie Regan
Linda Reilly
Jonathan Rose
R. Ian Storer
Hit Discovery, Discovery Sciences, R&D, AstraZeneca, 1 Francis Crick Ave, Cambridge CB2 0AA, U.K.
Jingwen Wang
Xiang Zhai
Iacovos N. Michaelides
Kevin Moreau